PATENT CLAIM ANALYSIS

Application Number: 16292473
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-06
Patent Classification: ["514", "561000"]

Abstract:
A method for relieving menstrual pain and reducing menstrual blood loss in a female is provided. The method comprises administering to the female an oral combination drug formulation comprising a first therapeutically effective dose of a non-steroidal anti-inflammatory drug (NSAID) and a second complementary low dose of tranexamic acid, wherein the NSAID is formulated to relieve the menstrual pain and to reduce a volume of menstrual blood loss of the female, wherein the dose of tranexamic acid ranges from 50 mg to 425 mg per oral combination drug formulation.

Claim (Index 15):
The method of  claim 12 , wherein the oral combination drug formulation comprises 200 mg of the ibuprofen and from 100 mg to 125 mg of the tranexamic acid, wherein the oral combination drug formulation is administered three times daily to treat the female with no clinical diagnosis related to dysmenorrhea and menorrhagia.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 99.0
- Lexical Diversity: 1.75926
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12714181', '12433510', '13016800', '13230902', '14017530']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7876917863500712
- 35 USC 102 Novelty (BERT): 0.5410133426661063
- Combined Prediction Score: 0.7630239419816748
- Mean Citation Score: 351.910706
- Max Citation Score: 386.66403
- Similarity Product: 282.7343313327009

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test